Macquarie Group Ltd

SEC CIK: 0001418333
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

TCRX holding history

TScan Therapeutics, Inc. in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TCRX overview All 13F holders of TCRX Full Q2 2026 holdings

Shares (Q4 2024): 0; Sold out in Q4 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2024

Holdings of TCRX by Macquarie Group Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2024	0	$0	0.0%	−1,047−100.0%	Sold out	Holders
Q3 2024	1,047	$5.21K	<0.1%	+1,047	New	Holders
Q2 2024	0	$0	0.0%	−1,618−100.0%	Sold out	Holders
Q1 2024	1,618	$13	<0.1%	+1,618	New	Holders